Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lyra Therapeutics Inc (NQ: LYRA )

0.5215 -3.5085 (-87.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 108,645,982
Open 0.3914
Bid (Size) 0.4802 (1)
Ask (Size) 0.5080 (9)
Prev. Close 4.030
Today's Range 0.3600 - 0.6400
52wk Range 0.3600 - 6.790
Shares Outstanding 31,836,815
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
-89.97%
-89.97%
1 Month
-89.61%
-89.61%
3 Month
-89.31%
-89.31%
6 Month
-82.20%
-82.20%
1 Year
-80.02%
-80.02%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
DJT Stock: Trump Media Fires Accounting Firm, Hires Replacement After SEC Charges
Via InvestorPlace
Topics Government Regulatory Compliance
Exposures Legal Political Regulatory
ZK Stock IPO: When Does Zeekr Go Public? What Is the Zeekr IPO Price Range?
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
What 4 Analyst Ratings Have To Say About Lyra Therapeutics
Via Benzinga
Lyra Therapeutics: Q1 Earnings Insights
Via Benzinga
Lyra Therapeutics's Return On Capital Employed Insights
Via Benzinga
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
Via Benzinga
Topics Earnings
Exposures Financial
Warren Buffett Just Gave Up on Paramount (PARA) Stock
Via InvestorPlace
Why Is Lyra Therapeutics (LYRA) Stock Down 90% Today?
Via InvestorPlace
Why Lyra Therapeutics Stock Is Down 93% Today
Via Benzinga
LYRA Stock Earnings: Lyra Therapeutics Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Lyra Therapeutics: Q2 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Lyra's Mid-Stage Chronic Rhinosinusitis Candidate Study Progressed, Shares Fall
Via Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.